Terms: = Head and neck cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Diagnosis
18 results:
1. Exploring Potential Biomarkers in Oesophageal cancer: A Comprehensive Analysis.
Romanowicz A; Lukaszewicz-Zajac M; Mroczko B
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673838
[TBL] [Abstract] [Full Text] [Related]
2. The cxcr4 might be a potential biomarker for esophageal squamous cell carcinoma: A meta-analysis.
Chen P; Zhang YL; Zhang XL; Guo Y; Tang PP
Medicine (Baltimore); 2024 Apr; 103(14):e37681. PubMed ID: 38579048
[TBL] [Abstract] [Full Text] [Related]
3. Differentially Infiltrated Identification of Novel Diagnostic Biomarkers Associated with Immune Infiltration in Nasopharyngeal Carcinoma.
Gao P; Lu W; Hu S; Zhao K
Dis Markers; 2022; 2022():3934704. PubMed ID: 36438903
[TBL] [Abstract] [Full Text] [Related]
4. FOXA2 promotes esophageal cancer migration and metastasis by activating cxcr4 expression.
Chen Z; Xiao Q; Shen Y; Xue C
Biochem Biophys Res Commun; 2022 Oct; 625():16-22. PubMed ID: 35944359
[TBL] [Abstract] [Full Text] [Related]
5. Diagnostic Value of MRI Combined with cxcr4 Expression Level in Lymph Node Metastasis head and neck Squamous Cell Carcinoma.
Zhao J; Li X; Wang M; Liu F; Wang J
Comput Math Methods Med; 2022; 2022():4073918. PubMed ID: 35309836
[TBL] [Abstract] [Full Text] [Related]
6. Development of a Prognostic Signature Based on Autophagy-related Genes for head and neck Squamous Cell Carcinoma.
Jin Y; Qin X
Arch Med Res; 2020 Nov; 51(8):860-867. PubMed ID: 32948377
[TBL] [Abstract] [Full Text] [Related]
7. Identification of inflammatory mediators associated with metastasis of oral squamous cell carcinoma in experimental and clinical studies: systematic review.
Elhousiny M; Miller K; Ariyawadana A; Nimmo A
Clin Exp Metastasis; 2019 Dec; 36(6):481-492. PubMed ID: 31559586
[TBL] [Abstract] [Full Text] [Related]
8. NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12/cxcr4 pathway.
Gao XL; Zheng M; Wang HF; Dai LL; Yu XH; Yang X; Pang X; Li L; Zhang M; Wang SS; Wu JB; Tang YJ; Liang XH; Tang YL
BMC Cancer; 2019 Jul; 19(1):743. PubMed ID: 31357956
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological significance of chemokine receptor (CCR1, CCR3, CCR4, CCR5, CCR7 and cxcr4) expression in head and neck squamous cell carcinomas.
González-Arriagada WA; Lozano-Burgos C; Zúñiga-Moreta R; González-Díaz P; Coletta RD
J Oral Pathol Med; 2018 Sep; 47(8):755-763. PubMed ID: 29797610
[TBL] [Abstract] [Full Text] [Related]
10.
Fang HY; Münch NS; Schottelius M; Ingermann J; Liu H; Schauer M; Stangl S; Multhoff G; Steiger K; Gerngroß C; Jesinghaus M; Weichert W; Kühl AA; Sepulveda AR; Wester HJ; Wang TC; Quante M
Clin Cancer Res; 2018 Mar; 24(5):1048-1061. PubMed ID: 29208671
[No Abstract] [Full Text] [Related]
11. The Serum Concentrations of Chemokine CXCL12 and Its Specific Receptor cxcr4 in Patients with Esophageal cancer.
Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Szmitkowski M
Dis Markers; 2016; 2016():7963895. PubMed ID: 27041792
[TBL] [Abstract] [Full Text] [Related]
12. Expression of chemokine receptor cxcr4 is closely correlated with clinical outcome in human nasopharyngeal carcinoma.
Tao H; Wei Y; Wang C; Yang K; Huang W; Liu H; Li B
Tumour Biol; 2016 May; 37(5):6099-105. PubMed ID: 26611644
[TBL] [Abstract] [Full Text] [Related]
13. Chemokines and their receptors in esophageal cancer--the systematic review and future perspectives.
Łukaszewicz-Zając M; Mroczko B; Szmitkowski M
Tumour Biol; 2015 Aug; 36(8):5707-14. PubMed ID: 26130416
[TBL] [Abstract] [Full Text] [Related]
14. Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation.
Weinstock M; Aljawai Y; Morgan EA; Laubach J; Gannon M; Roccaro AM; Varga C; Mitsiades CS; Paba-Prada C; Schlossman R; Munshi N; Anderson KC; Richardson PP; Weller E; Ghobrial IM
Br J Haematol; 2015 Jun; 169(6):851-8. PubMed ID: 25833301
[TBL] [Abstract] [Full Text] [Related]
15. Diagnostic value of 16 cellular tumor markers for metastatic thyroid cancer: an immunohistochemical study.
Liang H; Zhong Y; Luo Z; Huang Y; Lin H; Zhan S; Xie K; Li QQ
Anticancer Res; 2011 Oct; 31(10):3433-40. PubMed ID: 21965758
[TBL] [Abstract] [Full Text] [Related]
16. Intratumoural level of SDF-1 correlates with survival in head and neck squamous cell carcinoma.
Clatot F; Picquenot JM; Choussy O; Gouérant S; Moldovan C; Schultheis D; Cornic M; François A; Blot E; Laberge-Le-Couteulx S
Oral Oncol; 2011 Nov; 47(11):1062-8. PubMed ID: 21840752
[TBL] [Abstract] [Full Text] [Related]
17. CXC chemokine receptor 4 immunodetection in the follicular variant of papillary thyroid carcinoma: comparison to galectin-3 and hector battifora mesothelial cell-1.
Torregrossa L; Faviana P; Filice ME; Materazzi G; Miccoli P; Vitti P; Fontanini G; Melillo RM; Santoro M; Basolo F
Thyroid; 2010 May; 20(5):495-504. PubMed ID: 20450430
[TBL] [Abstract] [Full Text] [Related]
18. Assessment of biomarkers for clinical diagnosis of papillary thyroid carcinoma with distant metastasis.
Liang H; Zhong Y; Luo Z; Huang Y; Lin H; Luo M; Zhan S; Xie K; Ma Y; Li QQ
Int J Biol Markers; 2010; 25(1):38-45. PubMed ID: 20306451
[TBL] [Abstract] [Full Text] [Related]
